• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首次复发时间作为头颈部鳞状细胞癌患者生存的一项结局指标及预测因素。

Time to first relapse as an outcome and a predictor of survival in patients with squamous cell carcinoma of the head and neck.

作者信息

Hall S F, Groome P A, Rothwell D

机构信息

Department of Otolaryngology, Queen's University, Kingston, Ontario, Canada.

出版信息

Laryngoscope. 2000 Dec;110(12):2041-6. doi: 10.1097/00005537-200012000-00012.

DOI:10.1097/00005537-200012000-00012
PMID:11129017
Abstract

OBJECTIVE

To identify patterns and predictors of relapse and to determine whether the time to relapse influences survival.

STUDY DESIGN

Multivariate anal. ysis of prospective database.

METHODS

We present findings in 446 consecutive prospective patients from a regional cancer center with invasive squamous cell carcinoma who were treated for cure and were declared disease free. Time to relapse, site of relapse, and survival are reported by stage and site using bivariate and multivariate analysis.

RESULTS

Thirty-six percent of patients relapsed. The median time to relapse was 8.3 months, and 95% of relapses occurred within 3 years. T stage in the TNM staging system was associated with relapse, and N stage was not. In patients who relapsed before the median time to relapse, prognosis was worse than in those who relapsed after that time.

摘要

目的

确定复发模式及预测因素,并确定复发时间是否影响生存率。

研究设计

对前瞻性数据库进行多变量分析。

方法

我们报告了来自一个地区癌症中心的446例连续前瞻性患者的研究结果,这些患者患有浸润性鳞状细胞癌,接受了根治性治疗并被宣布无疾病。通过双变量和多变量分析,按分期和部位报告复发时间、复发部位和生存率。

结果

36%的患者复发。复发的中位时间为8.3个月,95%的复发发生在3年内。TNM分期系统中的T分期与复发相关,而N分期与复发无关。在复发时间中位数之前复发的患者,其预后比在该时间之后复发的患者更差。

相似文献

1
Time to first relapse as an outcome and a predictor of survival in patients with squamous cell carcinoma of the head and neck.首次复发时间作为头颈部鳞状细胞癌患者生存的一项结局指标及预测因素。
Laryngoscope. 2000 Dec;110(12):2041-6. doi: 10.1097/00005537-200012000-00012.
2
Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.腮腺转移——头颈部皮肤鳞状细胞癌的一个独立预后因素。
J Plast Reconstr Aesthet Surg. 2006;59(12):1288-93. doi: 10.1016/j.bjps.2006.03.043. Epub 2006 Jun 5.
3
Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.肛管鳞状细胞癌:治疗结果的预测因素
Dis Colon Rectum. 2008 Feb;51(2):147-53. doi: 10.1007/s10350-007-9125-z. Epub 2008 Jan 8.
4
The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.局部晚期头颈癌患者接受手术及术后放疗时不同治疗时间贫血的预后价值
Clin Oncol (R Coll Radiol). 2007 May;19(4):228-33. doi: 10.1016/j.clon.2007.02.009. Epub 2007 Mar 12.
5
Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.头颈部皮肤鳞状细胞癌的淋巴结转移
Laryngoscope. 2005 Sep;115(9):1561-7. doi: 10.1097/01.mlg.0000173202.56739.9f.
6
Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.头颈部鳞状细胞癌放疗后颈部清扫术:病理残留癌模式及预后
Head Neck. 2009 Mar;31(3):328-37. doi: 10.1002/hed.20976.
7
Detection of micrometastatic tumor cells in head and neck squamous cell carcinoma. A possible predictor of recurrences?头颈部鳞状细胞癌中微转移肿瘤细胞的检测。它可能是复发的预测指标吗?
Saudi Med J. 2007 Feb;28(2):216-20.
8
Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible?复发性晚期(T3或T4)头颈部鳞状细胞癌:挽救是否可行?
Arch Otolaryngol Head Neck Surg. 2004 Jan;130(1):35-8. doi: 10.1001/archotol.130.1.35.
9
Chemoprevention of head and neck cancer with retinoids: a negative result.维甲酸对头颈部癌症的化学预防:一项阴性结果。
Arch Otolaryngol Head Neck Surg. 2005 Mar;131(3):198-203. doi: 10.1001/archotol.131.3.198.
10
[The results of combined treatment (surgery and postoperative radiotherapy) for tongue cancer and prognostic factors].[舌癌综合治疗(手术及术后放疗)的结果与预后因素]
Kulak Burun Bogaz Ihtis Derg. 2007;17(1):1-6.

引用本文的文献

1
Characterizing head and neck cancer survivors' discontinuation of survivorship care.描述头颈部癌症幸存者停止接受生存护理的情况。
Cancer. 2022 Jan 1;128(1):192-202. doi: 10.1002/cncr.33888. Epub 2021 Aug 30.
2
Variation in routine follow-up care after curative treatment for head-and-neck cancer: a population-based study in Ontario.头颈部癌根治性治疗后常规随访护理的差异:安大略省一项基于人群的研究
Curr Oncol. 2018 Apr;25(2):e120-e131. doi: 10.3747/co.25.3892. Epub 2018 Apr 30.
3
Economic burden of resected squamous cell carcinoma of the head and neck in an incident cohort of patients in the UK.
英国一组初发头颈鳞状细胞癌患者手术切除后的经济负担
Head Neck Oncol. 2011 Oct 28;3:47. doi: 10.1186/1758-3284-3-47.